GMS | Deutscher Rheumatologiekongress 2023 | Rituximab vs. combination of Rituximab and Cyclophosphamide induction therapy for ANCA-associated vasculitis: A retrospective study

Figure 2: Prednisolone reduction. RTX (RAVE) and RTX/CYC (RITUXVAS) were superior to CYC (CYCLOPS) in AAV and GPA.

gms | German Medical Science